282 related articles for article (PubMed ID: 30979738)
1. IL23-Producing Human Lung Cancer Cells Promote Tumor Growth via Conversion of Innate Lymphoid Cell 1 (ILC1) into ILC3.
Koh J; Kim HY; Lee Y; Park IK; Kang CH; Kim YT; Kim JE; Choi M; Lee WW; Jeon YK; Chung DH
Clin Cancer Res; 2019 Jul; 25(13):4026-4037. PubMed ID: 30979738
[TBL] [Abstract][Full Text] [Related]
2. NCR
Liu Y; Song Y; Lin D; Lei L; Mei Y; Jin Z; Gong H; Zhu Y; Hu B; Zhang Y; Zhao L; Teo HY; Qiu J; Jiang W; Dong C; Wu D; Huang Y; Liu H
EBioMedicine; 2019 Mar; 41():333-344. PubMed ID: 30827928
[TBL] [Abstract][Full Text] [Related]
3. Type 3 innate lymphoid cell: a new player in liver fibrosis progression.
Wang S; Li J; Wu S; Cheng L; Shen Y; Ma W; She W; Yang C; Wang J; Jiang W
Clin Sci (Lond); 2018 Dec; 132(24):2565-2582. PubMed ID: 30459204
[TBL] [Abstract][Full Text] [Related]
4. Fingolimod Alters Tissue Distribution and Cytokine Production of Human and Murine Innate Lymphoid Cells.
Eken A; Yetkin MF; Vural A; Okus FZ; Erdem S; Azizoglu ZB; Haliloglu Y; Cakir M; Turkoglu EM; Kilic O; Kara I; Dönmez Altuntaş H; Oukka M; Kutuk MS; Mirza M; Canatan H
Front Immunol; 2019; 10():217. PubMed ID: 30828332
[TBL] [Abstract][Full Text] [Related]
5. Interleukin-12 and -23 Control Plasticity of CD127(+) Group 1 and Group 3 Innate Lymphoid Cells in the Intestinal Lamina Propria.
Bernink JH; Krabbendam L; Germar K; de Jong E; Gronke K; Kofoed-Nielsen M; Munneke JM; Hazenberg MD; Villaudy J; Buskens CJ; Bemelman WA; Diefenbach A; Blom B; Spits H
Immunity; 2015 Jul; 43(1):146-60. PubMed ID: 26187413
[TBL] [Abstract][Full Text] [Related]
6. Suppression of Aiolos and Ikaros expression by lenalidomide reduces human ILC3-ILC1/NK cell transdifferentiation.
Mazzurana L; Forkel M; Rao A; Van Acker A; Kokkinou E; Ichiya T; Almer S; Höög C; Friberg D; Mjösberg J
Eur J Immunol; 2019 Sep; 49(9):1344-1355. PubMed ID: 31151137
[TBL] [Abstract][Full Text] [Related]
7. Interleukin 6 Increases Production of Cytokines by Colonic Innate Lymphoid Cells in Mice and Patients With Chronic Intestinal Inflammation.
Powell N; Lo JW; Biancheri P; Vossenkämper A; Pantazi E; Walker AW; Stolarczyk E; Ammoscato F; Goldberg R; Scott P; Canavan JB; Perucha E; Garrido-Mesa N; Irving PM; Sanderson JD; Hayee B; Howard JK; Parkhill J; MacDonald TT; Lord GM
Gastroenterology; 2015 Aug; 149(2):456-67.e15. PubMed ID: 25917784
[TBL] [Abstract][Full Text] [Related]
8. Biological Therapy in Inflammatory Bowel Disease Patients Partly Restores Intestinal Innate Lymphoid Cell Subtype Equilibrium.
Creyns B; Jacobs I; Verstockt B; Cremer J; Ballet V; Vandecasteele R; Vanuytsel T; Ferrante M; Vermeire S; Van Assche G; Ceuppens JL; Breynaert C
Front Immunol; 2020; 11():1847. PubMed ID: 32983101
[TBL] [Abstract][Full Text] [Related]
9. Innate Lymphoid Cells in Intestinal Inflammation.
Geremia A; Arancibia-Cárcamo CV
Front Immunol; 2017; 8():1296. PubMed ID: 29081776
[TBL] [Abstract][Full Text] [Related]
10. Composition of innate lymphoid cell subsets in the human skin: enrichment of NCR(+) ILC3 in lesional skin and blood of psoriasis patients.
Teunissen MBM; Munneke JM; Bernink JH; Spuls PI; Res PCM; Te Velde A; Cheuk S; Brouwer MWD; Menting SP; Eidsmo L; Spits H; Hazenberg MD; Mjösberg J
J Invest Dermatol; 2014 Sep; 134(9):2351-2360. PubMed ID: 24658504
[TBL] [Abstract][Full Text] [Related]
11. The tumour microenvironment shapes innate lymphoid cells in patients with hepatocellular carcinoma.
Heinrich B; Gertz EM; Schäffer AA; Craig A; Ruf B; Subramanyam V; McVey JC; Diggs LP; Heinrich S; Rosato U; Ma C; Yan C; Hu Y; Zhao Y; Shen TW; Kapoor V; Telford W; Kleiner DE; Stovroff MK; Dhani HS; Kang J; Fishbein T; Wang XW; Ruppin E; Kroemer A; Greten TF; Korangy F
Gut; 2022 Jun; 71(6):1161-1175. PubMed ID: 34340996
[TBL] [Abstract][Full Text] [Related]
12. STAT1 Represses Cytokine-Producing Group 2 and Group 3 Innate Lymphoid Cells during Viral Infection.
Stier MT; Goleniewska K; Cephus JY; Newcomb DC; Sherrill TP; Boyd KL; Bloodworth MH; Moore ML; Chen K; Kolls JK; Peebles RS
J Immunol; 2017 Jul; 199(2):510-519. PubMed ID: 28576981
[TBL] [Abstract][Full Text] [Related]
13. Major Role of the IL17/23 Axis in Psoriasis Supports the Development of New Targeted Therapies.
Bugaut H; Aractingi S
Front Immunol; 2021; 12():621956. PubMed ID: 33717124
[TBL] [Abstract][Full Text] [Related]
14. Inflammatory triggers associated with exacerbations of COPD orchestrate plasticity of group 2 innate lymphoid cells in the lungs.
Silver JS; Kearley J; Copenhaver AM; Sanden C; Mori M; Yu L; Pritchard GH; Berlin AA; Hunter CA; Bowler R; Erjefalt JS; Kolbeck R; Humbles AA
Nat Immunol; 2016 Jun; 17(6):626-35. PubMed ID: 27111143
[TBL] [Abstract][Full Text] [Related]
15. Innate lymphoid cells exhibited IL-17-expressing phenotype in active tuberculosis disease.
Pan L; Chen X; Liu X; Qiu W; Liu Y; Jiang W; Zheng Y; Mou Y; Xu W; Li X; Ge H; Zhu H
BMC Pulm Med; 2021 Oct; 21(1):318. PubMed ID: 34641843
[TBL] [Abstract][Full Text] [Related]
16. Eomes Expression Defines Group 1 Innate Lymphoid Cells During Metastasis in Human and Mouse.
Verma R; Er JZ; Pu RW; Sheik Mohamed J; Soo RA; Muthiah HM; Tam JKC; Ding JL
Front Immunol; 2020; 11():1190. PubMed ID: 32625207
[TBL] [Abstract][Full Text] [Related]
17. Subsets of ILC3-ILC1-like cells generate a diversity spectrum of innate lymphoid cells in human mucosal tissues.
Cella M; Gamini R; Sécca C; Collins PL; Zhao S; Peng V; Robinette ML; Schettini J; Zaitsev K; Gordon W; Bando JK; Yomogida K; Cortez V; Fronick C; Fulton R; Lin LL; Gilfillan S; Flavell RA; Shan L; Artyomov MN; Bowman M; Oltz EM; Jelinsky SA; Colonna M
Nat Immunol; 2019 Aug; 20(8):980-991. PubMed ID: 31209406
[TBL] [Abstract][Full Text] [Related]
18. Innate lymphoid cells in intestinal cancer development.
Atreya I; Kindermann M; Wirtz S
Semin Immunol; 2019 Feb; 41():101267. PubMed ID: 30772139
[TBL] [Abstract][Full Text] [Related]
19. Dissecting human ILC heterogeneity: more than just three subsets.
Simoni Y; Newell EW
Immunology; 2018 Mar; 153(3):297-303. PubMed ID: 29140572
[TBL] [Abstract][Full Text] [Related]
20. Human ectoenzyme-expressing ILC3: immunosuppressive innate cells that are depleted in graft-versus-host disease.
Hazenberg MD; Haverkate NJE; van Lier YF; Spits H; Krabbendam L; Bemelman WA; Buskens CJ; Blom B; Shikhagaie MM
Blood Adv; 2019 Nov; 3(22):3650-3660. PubMed ID: 31751473
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
